Jason Cassorla
Stock Analyst at Citigroup
(2.60)
# 1,314
Out of 4,415 analysts
32
Total ratings
56%
Success rate
0.39%
Average return
Main Sectors:
10 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
UHS Universal Health Services | Maintains: Buy | $170 → $193 | $167.70 | +15.09% | 5 | Feb 29, 2024 | |
SGRY Surgery Partners | Maintains: Buy | $43 → $42 | $24.53 | +71.22% | 4 | Feb 27, 2024 | |
HCA HCA Healthcare | Maintains: Buy | $324 → $279 | $307.76 | -9.34% | 5 | Oct 25, 2023 | |
AGTI Agiliti | Downgrades: Neutral | $20 → $13 | $10.10 | +28.71% | 4 | Aug 15, 2023 | |
CLOV Clover Health Investments | Maintains: Neutral | $1 → $1.5 | $0.70 | +115.83% | 3 | Aug 11, 2023 | |
THC Tenet Healthcare | Maintains: Buy | $83 → $90 | $120.28 | -25.17% | 5 | Aug 1, 2023 | |
CYH Community Health Systems | Maintains: Buy | $9 → $7 | $3.42 | +104.68% | 2 | May 3, 2023 | |
EHAB Enhabit | Maintains: Neutral | $16 → $18 | $10.18 | +76.82% | 2 | Feb 17, 2023 | |
INNV InnovAge Holding | Maintains: Neutral | $5 → $8 | $4.08 | +96.08% | 1 | Nov 16, 2022 | |
ATIP ATI Physical Therapy | Maintains: Neutral | $70 → $60 | $4.47 | +1,242.25% | 1 | Nov 8, 2022 |
Universal Health Services
Feb 29, 2024
Maintains: Buy
Price Target: $170 → $193
Current: $167.70
Upside: +15.09%
Surgery Partners
Feb 27, 2024
Maintains: Buy
Price Target: $43 → $42
Current: $24.53
Upside: +71.22%
HCA Healthcare
Oct 25, 2023
Maintains: Buy
Price Target: $324 → $279
Current: $307.76
Upside: -9.34%
Agiliti
Aug 15, 2023
Downgrades: Neutral
Price Target: $20 → $13
Current: $10.10
Upside: +28.71%
Clover Health Investments
Aug 11, 2023
Maintains: Neutral
Price Target: $1 → $1.5
Current: $0.70
Upside: +115.83%
Tenet Healthcare
Aug 1, 2023
Maintains: Buy
Price Target: $83 → $90
Current: $120.28
Upside: -25.17%
Community Health Systems
May 3, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $3.42
Upside: +104.68%
Enhabit
Feb 17, 2023
Maintains: Neutral
Price Target: $16 → $18
Current: $10.18
Upside: +76.82%
InnovAge Holding
Nov 16, 2022
Maintains: Neutral
Price Target: $5 → $8
Current: $4.08
Upside: +96.08%
ATI Physical Therapy
Nov 8, 2022
Maintains: Neutral
Price Target: $70 → $60
Current: $4.47
Upside: +1,242.25%